Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Multi-drug Resistant Tuberculosis”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Large-scale testing (Phase 3)Study completedNCT03896685
What this trial is testing

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisPulmonary Tuberculoses+3 more
Médecins Sans Frontières, France 323
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Testing effectiveness (Phase 2)Study completedNCT00425113
What this trial is testing

Metronidazole for Pulmonary Tuberculosis (South Korea)

Who this might be right for
TuberculosisMulti-Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT02365623
What this trial is testing

An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Janssen Pharmaceutical K.K. 6
Large-scale testing (Phase 3)Study completedNCT04207112
What this trial is testing

Economic Evaluation of New MDR TB Regimens

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculoses
Medecins Sans Frontieres, Netherlands 73
Post-approval studies (Phase 4)Study completedNCT00495339
What this trial is testing

MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Sanofi 100
Large-scale testing (Phase 3)Study completedNCT01424670
What this trial is testing

Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis

Who this might be right for
Multidrug-resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 511
Not applicableStudy completedNCT02274389
What this trial is testing

A Prospective Patient Registry of Patients Exposed to Bedaquiline

Who this might be right for
Pulmonary Multi-drug Resistant Tuberculosis
Janssen Research & Development, LLC 5
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Large-scale testing (Phase 3)Looking for participantsNCT06905522
What this trial is testing

A PAN-USR TB Multi-Center Trial

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 610
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Not applicableStudy completedNCT07135622
What this trial is testing

Xpert MTB/RIF Ultra Trial

Who this might be right for
Tuberculosis (TB)Pulmonary TB
Nestani Tukvadze 778
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableNot Yet RecruitingNCT07191834
What this trial is testing

A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

Who this might be right for
Rifampicin-resistant/Multidrug-resistant Pulmonary TuberculosisType 2 Diabetes Mellitus (T2DM)Pretomanid
Wuhan Pulmonary Hospital 60
Early research (Phase 1)Study completedNCT04493671
What this trial is testing

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Who this might be right for
Pulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more
Global Alliance for TB Drug Development 137
Load More Results